FDA Emphasizing Supplier Controls
In the wake of recent drug quality incidents such as heparin contamination, the FDA is seriously considering how drug ingredient supply chains need to be audited, according to staff from CDER’s Officer of Compliance. Steve Wolfgang, a consumer safety officer … Continue reading